The research involved a team from the University of Maryland and Burkina Faso conducting the first outside-of-a-laboratory trial of a transgenic method for combating malaria.

Last week, LSHTM hosted the Mass Drug Administration (MDA) and Antimicrobial Resistance (AMR) Symposium.

Economists have been centrally involved in the Malaria Centre from the outset, contributing evidence to support a series of key policy recommendations over the past two decades.